Cipla Limited generated around 70.6 million U.S. dollars in revenue from its active pharmaceutical ingredient business in financial year 2023. The company saw a significant decrease in growth in this business segment compared to the previous fiscal year.
Revenue from active pharmaceutical ingredients of Cipla Limited from financial year 2017 to 2023 (in million U.S. dollars)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$229 USD $199 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Cipla's BSE market price FY 2021-2023
- Premium Statistic Cipla's shareholders 2023, by type
- Premium Statistic Cipla's revenue share 2023, by medical therapy
- Premium Statistic Cipla's gross revenue FY 2015-2023
- Premium Statistic Cipla's dividend value FY 2009-2023
- Premium Statistic Cipla's CSR expenditure 2020 by project
- Premium Statistic Cipla's number of employees 2018 by category
- Premium Statistic Cipla's global revenue 2023, by region
- Premium Statistic Cipla's SAGA revenue FY 2017-2018
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2022
About the region
10
- Premium Statistic Cipla's global revenue share 2023, by region
- Premium Statistic Cipla's EBITDA margin FY 2014-2023
- Premium Statistic Cipla's global API revenue share 2023, by region
- Premium Statistic Cipla's R&D investment share FY 2014-2023
- Premium Statistic Cipla's profit FY 2009-2023
- Premium Statistic Cipla's income from operations FY 2014-2023
- Premium Statistic Net profit of major pharma companies India 2022
- Premium Statistic GSK Pharmaceuticals' net profit India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' remuneration of executive directors in India 2023
- Premium Statistic GSK Pharmaceuticals' revenue share from operations in India FY 2015-2023
Selected statistics
6
- Basic Statistic Merck & Co total assets 2009-2022
- Premium Statistic Merck & Co - expenditure on research and development 2006-2022
- Basic Statistic Merck & Co cash dividends declared 2006-2022
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2022
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
Other regions
10
- Premium Statistic Biogen's top products based on revenue 2020-2022
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Employees in select life sciences sectors by leading US state 2016 vs. 2021
- Premium Statistic Life science companies in California 2019-2021, by sector
- Premium Statistic Mexico: pharma industry market value 2008-2016
- Premium Statistic Leading pharma companies in greater China 2017, by market value growth rate
- Basic Statistic Usage rate of top drug classes prescribed to seniors in Canada 2016, by age
- Premium Statistic Venezuela: pharma industry market value 2008-2017
- Premium Statistic Pharma market value in Argentina 2008-2021
Related statistics
10
- Premium Statistic GSK Pharmaceuticals' EBITDA in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' share of income utilized in India 2023, by category
- Premium Statistic GSK Pharmaceuticals' total income in India FY 2017-2023
- Premium Statistic GSK Pharmaceuticals' number of employees in India FY 2016-2023
- Premium Statistic GSK Pharmaceuticals' market price of shares at NSE India FY 2023, by month
- Premium Statistic GSK Pharmaceuticals' operation revenue in India FY 2014-2023
- Premium Statistic GSK Pharmaceuticals' earnings per share in India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' net assets India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' book value per share India FY 2015-2023
- Premium Statistic GSK Pharmaceuticals' shareholder distribution India FY 2023
Further related statistics
10
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- Pfizer's ad spending 2008-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- Foreign exchange earnings from tourism in India 2000-2021
- International tourism receipts of India 2011-2021
- Number of international tourist arrivals in India 2010-2021
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
Further Content: You might find this interesting as well
Statistics
- Celgene's revenue and net income 2006-2018
- M&A capacities - changes for the global pharma industry 2008-2015
- Expenditure worldwide on diabetes by market 2013-2018
- Pfizer's ad spending 2008-2022
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- Foreign exchange earnings from tourism in India 2000-2021
- International tourism receipts of India 2011-2021
- Number of international tourist arrivals in India 2010-2021
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
Cipla. (July 18, 2023). Revenue from active pharmaceutical ingredients of Cipla Limited from financial year 2017 to 2023 (in million U.S. dollars) [Graph]. In Statista. Retrieved October 03, 2023, from https://www.statista.com/statistics/986960/india-cipla-api-revenue/
Cipla. "Revenue from active pharmaceutical ingredients of Cipla Limited from financial year 2017 to 2023 (in million U.S. dollars)." Chart. July 18, 2023. Statista. Accessed October 03, 2023. https://www.statista.com/statistics/986960/india-cipla-api-revenue/
Cipla. (2023). Revenue from active pharmaceutical ingredients of Cipla Limited from financial year 2017 to 2023 (in million U.S. dollars). Statista. Statista Inc.. Accessed: October 03, 2023. https://www.statista.com/statistics/986960/india-cipla-api-revenue/
Cipla. "Revenue from Active Pharmaceutical Ingredients of Cipla Limited from Financial Year 2017 to 2023 (in Million U.S. Dollars)." Statista, Statista Inc., 18 Jul 2023, https://www.statista.com/statistics/986960/india-cipla-api-revenue/
Cipla, Revenue from active pharmaceutical ingredients of Cipla Limited from financial year 2017 to 2023 (in million U.S. dollars) Statista, https://www.statista.com/statistics/986960/india-cipla-api-revenue/ (last visited October 03, 2023)
Revenue from active pharmaceutical ingredients of Cipla Limited from financial year 2017 to 2023 (in million U.S. dollars) [Graph], Cipla, July 18, 2023. [Online]. Available: https://www.statista.com/statistics/986960/india-cipla-api-revenue/